S. Kantak

发表

XOMA 052, an anti-IL-1{beta} monoclonal antibody, improves glucose control and {beta}-cell function in the diet-induced obesity mouse model.

K. Maedler, A. Owyang, Erna Domsgen, 2010, Endocrinology.

Kinetic Approach to Pathway Attenuation Using XOMA 052, a Regulatory Therapeutic Antibody That Modulates Interleukin-1β Activity

P. Larsen, A. Mirza, J. Hunter, 2010, The Journal of Biological Chemistry.

Low dose radiation-induced endothelial cell retraction.

C. Diglio, J. Onoda, S. Kantak, 1993, International journal of radiation biology.

Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice.

A. Mirza, J. Hunter, Johnny Yin, 2011, Atherosclerosis.

Radiation induced endothelial cell retraction in vitro: Correlation with acute pulmonary edema

C. Diglio, J. Onoda, S. Kantak, 1999, Pathology & Oncology Research.

E-cadherin Regulates Anchorage-independent Growth and Survival in Oral Squamous Cell Carcinoma Cells*

R. Kramer, S. Kantak, 1998, The Journal of Biological Chemistry.

Discovery and structure-activity relationship of 2-phenyl-oxazole-4-carboxamide derivatives as potent apoptosis inducers.

L. Qiu, A. Estevez, P. Sabbatini, 2006, Bioorganic & medicinal chemistry letters.

Dominant-negative E-cadherin alters adhesion and reverses contact inhibition of growth in breast carcinoma cells.

R. Kramer, A. Tsiftsoglou, I. Vizirianakis, 2002, International journal of oncology.

Transfusion-Related Cost of Adjunct Aprotinin Application in One-Step Infected Hip Revision Arthroplasty – Cost-Minimizing Analysis

S. Kantak, G. Singbartl, H. Munkel, 2001, Transfusion Medicine and Hemotherapy.

WR-1065 and radioprotection of vascular endothelial cells. II. Morphology.

T. Saclarides, J. Podolski, J. Onoda, 1996, Radiation research.

Integrin α3β1 Engagement Disrupts Intercellular Adhesion

R. Kramer, C. Yao, S. Kantak, 2001 .

NKTR-214, an Engineered Cytokine with Biased IL2 Receptor Binding, Increased Tumor Exposure, and Marked Efficacy in Mouse Tumor Models

M. Addepalli, S. Doberstein, T. Sweeney, 2016, Clinical Cancer Research.

Efficacy of an Antagonistic Anti-CD40 Monoclonal Antibody, HCD122 (CHIR-12.12), in Preclinical Models of Human Non-Hodgkin’s Lymphoma and Hodgkin’s Disease.

M. Patawaran, N. Pryer, M. Luqman, 2006 .

HCD122, an Antagonist Human Anti-CD40 Monoclonal Antibody, Enhances Efficacy of CHOP in Tumor Xenograft Model of Human Diffuse Large B-Cell Lymphoma.

M. Luqman, S. Klabunde, S. Kantak, 2007 .

Utilisation d'anticorps anti-cd40

A. Mirza, M. Luqman, Yongyu Wang, 2006 .

Radiation Enhances Tumor Cell Metastasis

M. Piechocki, K. Honn, K. Nelson, 1993 .

Low Level Radiation Effects on Endothelial Cell Eicosanoid Biosynthesis

M. Piechocki, C. Diglio, J. Onoda, 1993 .

Inhibition of radiation-enhanced expression of integrin and metastatic potential in B16 melanoma cells by a lipoxygenase inhibitor.

M. Piechocki, K. Honn, J. Onoda, 1994, Radiation research.

Integrin alpha3beta1 engagement disrupts intercellular adhesion.

R. Kramer, C. Yao, S. Kantak, 2001, Experimental cell research.

Kinetic Approach to Pathway Attenuation Using XOMA 052, a Regulatory Therapeutic Antibody That Modulates Interleukin-1β Activity

P. Larsen, A. Mirza, J. Hunter, 2010, The Journal of Biological Chemistry.

XOMA 052, an anti-IL-1{beta} monoclonal antibody, improves glucose control and {beta}-cell function in the diet-induced obesity mouse model.

K. Maedler, A. Owyang, Erna Domsgen, 2010, Endocrinology.